MedPath

陕西汉唐制药有限公司

Ownership
-
Established
1994-10-24
Employees
-
Market Cap
-
Website
http://www.sxhantang.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

141

NMPA:141

Drug Approvals

得生胶囊

Approval Number
国药准字Z20090753
Approval Date
May 13, 2024
NMPA

银屑胶囊

Approval Number
国药准字Z20090752
Approval Date
May 13, 2024
NMPA

Sodium Citrate

Product Name
枸橼酸钠
Approval Number
国药准字H61022282
Approval Date
Oct 13, 2023
NMPA

芙蓉抗流感胶囊

Approval Number
国药准字Z20080587
Approval Date
Aug 7, 2023
NMPA

跌打生骨胶囊

Approval Number
国药准字Z20080444
Approval Date
Aug 7, 2023
NMPA

Lamivudine Oral Solution

Product Name
拉米夫定口服溶液
Approval Number
国药准字H20183112
Approval Date
Apr 23, 2023
NMPA

Lamivudine Oral Solution

Product Name
拉米夫定口服溶液
Approval Number
国药准字H20133135
Approval Date
Apr 23, 2023
NMPA

Loratadine Syrup

Product Name
氯雷他定糖浆
Approval Number
国药准字H20183084
Approval Date
Apr 23, 2023
NMPA

Compound Glycyrrhiza Oral Solution

Product Name
复方甘草口服溶液
Approval Number
国药准字H61021050
Approval Date
Apr 23, 2023
NMPA

Saponated Cresol Solution

Product Name
甲酚皂溶液
Approval Number
国药准字H61021053
Approval Date
Mar 29, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.